CAT and Alzheimer disease: Furthermore, ellagic acid pretreatment in intrahippocampal Aβ-microinjected rats, a model that mimics early-onset AD, mitigated oxidative stress by increasing the antioxidants catalase (CAT) and GSH and reducing the levels of malondialdehyde (MDA), a lipid peroxidation product [189].